Fig. 1From: A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United StatesOverview of study design. BL baseline. Note. The first migraine diagnosis date during the 12-month baseline period was considered the initial diagnosis dateBack to article page